Validity and Reliability the Turkish Version of the Oxford Participation and Activities Questionnaire in Older People

April 28, 2020 updated by: MERV KARAPINAR, Hacettepe University

Validity and Reliability the Turkish Version of the Oxford Participation and Activities Questionnaire (Ox-PAQ) in Older People

To evaluate the validity and reliability of Turkish version of the Oxford Participation and Activities Questionnaire (Ox-PAQ) for Turkish older population. Following the translation protocol of the Ox-PAQ, Short Form-12, Katz Index of Independence in Activities of Daily Living Scale, The Five Times Sit to Stand Test were administered to 230 older people. End of this study, occupational therapists, physiotherapists can use the it to assess activity and participation level of older people living in community

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Isparta, Turkey
        • Suleyman Demirel University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Older people (65 and older years)

Description

Inclusion Criteria:

  • Aged 65 years or older
  • Mini Mental State Examination score greater than 24,
  • Able to mobilize independently.

Exclusion Criteria:

  • Severe vision and hearing loss
  • Having an orthopaedic, vestibular, neurological or mental problem
  • Failure to cooperation
  • Presence of an acute disease during recovery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ox-PAQ
Time Frame: One year
It contains 23 items, each measured on a five-point Likert scale. Each of the 23 items is scored in the same direction (0=Never, 1=Rarely, 2=Sometimes, 3=Often, 4=Always). Also, Ox-PAQ consist of three domains, Routine Activities (14 items: nos. 1,2,3,4,5,6,7,8,9,10, 13,14,16,17), Social Engagement (4 items: nos. 11,12,15,18) and Emotional Well-Being (5 items: nos. 19,20,21,22,23). Raw scores of Ox-PAQ are transformed to a range from 0 to 100. The formula for scoring each dimension is as follows: sum of scores of each question in dimension/ ((4 x number of questions in dimension) x 100) (10). Higher scores reflect greater problems with activity and participation.
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: MERVE KARAPINAR, Suleyman Demirel University, Department of Physiotherapy and Rehabilitation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 10, 2018

Primary Completion (ACTUAL)

June 10, 2019

Study Completion (ACTUAL)

June 20, 2019

Study Registration Dates

First Submitted

April 26, 2020

First Submitted That Met QC Criteria

April 28, 2020

First Posted (ACTUAL)

April 30, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 30, 2020

Last Update Submitted That Met QC Criteria

April 28, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 191

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Aging

Clinical Trials on Questionnaire

3
Subscribe